CHEK2 and breast carcinoma: Also, although a study conducted in Belgium suggested that breast cancer patients with a CHEK2*1100delC mutation are, in general, not characterised by a distinct enhanced chromosomal radiosensitivity, this conclusion was based on only four breast cancer cases with the mutation who were compared with healthy controls without the mutation (Baeyens et al, 2005).